Integral Diagnostics Secures Bull on Merger -- Market Talk

Dow Jones

Dec 05, 2024

0001 GMT - Integral Diagnostics gets a new bull at Bell Potter in anticipation of the enhanced scale offered by the imaging provider's merger with Capitol Health. Analyst Martyn Jacobs tells clients in a note that the combined Integral-Capitol business will become Australia's third-largest imaging provider, creating operating leverage and opportunities in telehealth. He says that regulatory changes could allow the group to extend operating hours, generating an additional A$11 million in fiscal 2026 revenue. Bell Potter initiates coverage with a buy rating and A$3.87 target price on the stock, which is up 4.0% at A$3.16. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

December 04, 2024 19:01 ET (00:01 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2489127161"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489127161\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2489127161?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-05 08:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489127161","market":"hk","top_or_hot":-1,"title":"Integral Diagnostics Secures Bull on Merger -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0001 GMT - Integral Diagnostics gets a new bull at Bell Potter in anticipation of the enhanced scale offered by the imaging provider's merger with Capitol Health. Analyst Martyn Jacobs tells clients in a note that the combined Integral-Capitol business will become Australia's third-largest imaging provider, creating operating leverage and opportunities in telehealth. He says that regulatory changes could allow the group to extend operating hours, generating an additional A$11 million in fiscal 2026 revenue. Bell Potter initiates coverage with a buy rating and A$3.87 target price on the stock, which is up 4.0% at A$3.16. (stuart.condie@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 04, 2024 19:01 ET (00:01 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Integral Diagnostics Secures Bull on Merger -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntegral Diagnostics Secures Bull on Merger -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-12-05 08:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0001 GMT - Integral Diagnostics gets a new bull at Bell Potter in anticipation of the enhanced scale offered by the imaging provider's merger with Capitol Health. Analyst Martyn Jacobs tells clients in a note that the combined Integral-Capitol business will become Australia's third-largest imaging provider, creating operating leverage and opportunities in telehealth. He says that regulatory changes could allow the group to extend operating hours, generating an additional A$11 million in fiscal 2026 revenue. Bell Potter initiates coverage with a buy rating and A$3.87 target price on the stock, which is up 4.0% at A$3.16. (stuart.condie@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 04, 2024 19:01 ET (00:01 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INTEU","symbol_name":"Integral Acquisition Corporation 1","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2489127161","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489127161","pubTimestamp":1733356860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0001 GMT - Integral Diagnostics gets a new bull at Bell Potter in anticipation of the enhanced scale offered by the imaging provider's merger with Capitol Health. Analyst Martyn Jacobs tells clients in a note that the combined Integral-Capitol business will become Australia's third-largest imaging provider, creating operating leverage and opportunities in telehealth. He says that regulatory changes could allow the group to extend operating hours, generating an additional A$11 million in fiscal 2026 revenue. Bell Potter initiates coverage with a buy rating and A$3.87 target price on the stock, which is up 4.0% at A$3.16. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INTEU":"Integral Acquisition Corporation 1","IDX.AU":"INTEGRAL DIAGNOSTICS LTD","BK7124":"保健护理服务","CAJ.AU":"CAPITOL HEALTH LIMITED"},"translate_title":"Integral Diagnostics确保合并牛市——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INTEU":1,"CAJ.AU":0.9,"IDX.AU":0.9},"content_text":"0001 GMT - Integral Diagnostics gets a new bull at Bell Potter in anticipation of the enhanced scale offered by the imaging provider's merger with Capitol Health. Analyst Martyn Jacobs tells clients in a note that the combined Integral-Capitol business will become Australia's third-largest imaging provider, creating operating leverage and opportunities in telehealth. He says that regulatory changes could allow the group to extend operating hours, generating an additional A$11 million in fiscal 2026 revenue. Bell Potter initiates coverage with a buy rating and A$3.87 target price on the stock, which is up 4.0% at A$3.16. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 04, 2024 19:01 ET (00:01 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}